<?xml version="1.0" encoding="UTF-8"?>
<fig id="cancers-12-00713-f002" orientation="portrait" position="float">
 <label>Figure 2</label>
 <caption>
  <p>SAMHD1 modifies antiviral and activity of antimetabolites. Dose response of the nucleoside analogues (
   <bold>A</bold>) or anti-folate drugs (
   <bold>B</bold>) currently used as anti-cancer treatments in wild-type (■) or SAMHD1-depleted (Δ) MDMs. Inhibition of HIV infection was measured as the percentage of GFP+ cells relative to the no drug condition. Mean ±SD of at least three independent donors performed in duplicate is shown. * 
   <italic>p</italic> &lt; 0.05; ** 
   <italic>p</italic> &lt; 0.005; *** 
   <italic>p</italic> &lt; 0.0005.
  </p>
 </caption>
 <graphic xlink:href="cancers-12-00713-g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
